Human studies of a Novel Gel formulation containing Halofuginone Hydrobromide to establish safety,Tolerability and Preliminary efficacy uin single dose and multiple dose studies in patients with osmf
Funding Agency : BIRAC
ongoing
principle investigator
Rs19294000
2021 -
2023
IgG4 levels in the saliva of children with Autism spectrum disorders
Funding Agency : ICMR
Completed
Coinvestigator
26,00,000.00
2014 -
2019
Study of water quality from dental unit waterlines in dental practice from selected dental clinics in Mangalore
Human studies of a Novel Gel formulation containing Halofuginone Hydrobromide to establish safety,Tolerability and Preliminary efficacy uin single dose and multiple dose studies in patients with osmf
A novel mucoadhesive delivery platform containing dapsone as a treatment modality for oral lichen planus with enhanced tolerability and improved efficacy.